Seminar on Quality Control on Cell Products for Therapy and Experience-Sharing on Submission
Seminar on “Quality Control on Cell Products for Therapy and Experience-Sharing on Submission” was held on August 13 with Dr. Hsiao Hsiu-Ling, CEO of Ever Supreme Bio Technology Company as keynote speaker on discussion of preparation for application to FDA & TFDA on clinical trials related to cell therapy in the United States and Taiwan. The talk covered laws and regulations, matters to be prepared, and experience sharing.